Induced Pluripotent Stem Cell (iPSC)–Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges

PURPOSE OF REVIEW: In the rapidly developing field of adoptive cell immunotherapy, there is urgent need for discoveries that would improve outcomes, extend the applicability, and reduce the costs. Induced pluripotent stem cells (iPSC) can be a source of broadly applicable cellular immunotherapeutics...

Descripción completa

Detalles Bibliográficos
Autores principales: Nianias, Alexandros, Themeli, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
CART and Immunotherapy (M Ruella and P Hanley, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647376/
https://www.ncbi.nlm.nih.gov/pubmed/31243643
http://dx.doi.org/10.1007/s11899-019-00528-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647376/
https://www.ncbi.nlm.nih.gov/pubmed/31243643
http://dx.doi.org/10.1007/s11899-019-00528-6

Ejemplares similares